These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20856599)

  • 1. Getting the balance right: Established and emerging therapies for major depressive disorders.
    Perović B; Jovanović M; Miljković B; Vezmar S
    Neuropsychiatr Dis Treat; 2010 Sep; 6():343-64. PubMed ID: 20856599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.
    Millan MJ
    Neurotherapeutics; 2009 Jan; 6(1):53-77. PubMed ID: 19110199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.
    Pandi-Perumal SR; Trakht I; Srinivasan V; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    World J Biol Psychiatry; 2009; 10(4 Pt 2):342-54. PubMed ID: 18609422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine: innovative pharmacological approach in depression.
    Popoli M
    CNS Drugs; 2009; 23 Suppl 2():27-34. PubMed ID: 19708723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
    Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
    BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for the treatment of depression in people with cancer.
    Vita G; Compri B; Matcham F; Barbui C; Ostuzzi G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD011006. PubMed ID: 36999619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe depression: is there a best approach?
    Sonawalla SB; Fava M
    CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of newer medications for treating depression in primary care patients.
    Mulrow CD; Williams JW; Chiquette E; Aguilar C; Hitchcock-Noel P; Lee S; Cornell J; Stamm K
    Am J Med; 2000 Jan; 108(1):54-64. PubMed ID: 11059441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple uptake inhibitors: therapeutic potential in depression and beyond.
    Chen Z; Skolnick P
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1365-77. PubMed ID: 17714023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.